Idex Corp. narrows FY25 adjusted EPS view to $7.86-$7.91 from $7.85-$7.95

Consensus $7.88. Backs FY25 organic sales view up 1%. The company said it is on track to achieve at least 100% free cash flow conversion for full year 2025. The company said, “We support our growth efforts with a balanced capital deployment strategy, prioritizing allocation towards the highest return areas. In the near-term, we expect to continue our focus on returning capital to shareholders as we optimize our growth platform playbook and execute complementary bolt-on acquisitions. As we continue to execute our growth strategy, we are confident that we can achieve attractive growth and consistent value creation long-term.”